Previous Article | Next Article 
J Virol, May 1998, p. 4049-4056, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Control of Adenovirus Early Gene Expression
during the Late Phase of Infection
Shawn P.
Fessler and
C. S. H.
Young*
Department of Microbiology, Columbia
University, New York, New York 10032
Received 7 October 1997/Accepted 9 February 1998
 |
ABSTRACT |
The adenovirus gene regulatory program occurs in two distinct
phases, as defined by the onset of DNA replication. During the early
phase, the E1A, E1B, E2, E3, and E4 genes are maximally expressed,
while the major late promoter (MLP) is minimally expressed and
transcription is attenuated. After the onset of DNA replication, the
IVa2 and pIX genes are expressed at high levels, transcription from the
MLP is unattenuated and fully activated, and early gene expression is
repressed. Although the cis elements and
trans-acting factors responsible for the late-phase
activation of the MLP have been identified and characterized and the
role of DNA replication in activation has been established, the
mechanism(s) underlying the commensurate decrease in early gene
expression has yet to be elucidated. The results of this study
demonstrate that this decrease depends on a fully functional MLP.
Specifically, virus mutants with severely deficient transcription from
the MLP exhibit a marked increase in expression of the E1A, E1B, and E2
early genes. These increases were observed at the level of
transcription initiation, mRNA accumulation, and protein production. In
addition, expression from the late gene pIX, which is not contained
within the major late transcription unit (MLTU), is also markedly
increased. To begin the analysis of the mechanisms underlying these
late-phase effects, mixed-infection experiments with mutant and
wild-type viruses were performed. The results show that the effects on
early gene expression, as measured both at the protein and RNA levels, are mediated in trans and not in cis. These
observations are consistent either with a model in which one or more
late protein products encoded by the MLTU acts as a repressor of early
gene expression or with one in which the wild-type MLP competes with
early promoters for limiting transcription factors.
 |
INTRODUCTION |
Extensive studies of adenovirus gene
regulation have uncovered the complexity of the gene expression
program during the course of infection. Not only are adenovirus genes
regulated in a temporal manner, but viral gene products also exert
control at every step in the gene expression pathway, from
transcription initiation to protein modification. Both early and late
gene products are involved in transcriptional activation (E1A, E2A, E4,
IX, and IVa2 [10, 21, 24, 35, 36, 44, 55, 59]),
various stages of RNA processing (E1B, E2, and E4 [1, 2, 6, 25, 42, 43, 45, 51]), and translational efficiency (L4 100-kDa [100K] protein [22]). In addition, VA RNA, a short
(157-nucleotide) RNA polymerase III transcript, also has a regulatory
role, as it blocks global shutdown of protein synthesis in the host
cell by interfering with the inhibitory action of DAI kinase
(37). cis-acting elements also have a wide range
of effects beyond the binding of transcription factors, as they are
involved in determination of splice site choice (29),
polyadenylation site choice (20, 46-48), and mRNA
translational efficiency (15).
Within this diversity of levels and mechanisms of gene expression
control, the most prominent regulatory event in the adenovirus life
cycle is the early-to-late switch in infection (Fig.
1). At early times (from the time of
adsorption to about 6 h postinfection [p.i.]), the early genes
E1A, E1B, E2, E3, and E4, all of which are activated by the immediate
early gene E1A (4, 26), are maximally expressed, and the
major late transcription unit (MLTU) is expressed at very low levels
and is attenuated (41, 53). At the onset of viral DNA
replication (~6 h p.i.), a marked switch in gene expression occurs.
At this time, transcription is activated at three different
transcription units: IVa2, located at 16 map units (m.u.), pIX, located
at 10 m.u., and the MLTU, located at 17 m.u. The activation
of late genes is accompanied by a reduction in the expression of early
genes, as measured per genome (reviewed in references
39 and 52). Whether this
reduction is a passive consequence of high levels of gene activity from
the late promoters or is an active repression has not been conclusively
determined.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Transcriptional map of adenovirus, depicting the
early-to-late switch in infection. (A) At early times (0 to 6 h
p.i.), transcription of early genes E1A to E4 is at a maximum, as
represented by heavy arrows, and MLP transcription is at a minimum, as
represented by a lighter arrow, and attenuated. (B) At later times
(after the onset of DNA replication at about 6 h p.i.), MLP
transcription is fully activated and unattenuated and early gene
expression per genome is reduced. Late genes pIX and IVa2 are also
expressed at high levels.
|
|
Studies of late gene expression from the major late promoter (MLP) have
implicated both trans-acting factors and cis
effects in the late-phase-specific activation of the MLP. Not only has it been known for many years that the E1A 289R protein can
transactivate the MLP (38), but recent data show that the
late-phase-specific protein IVa2, expressed from a gene lying outside
the MLTU, up-regulates the MLP through binding to the DEF sites
downstream of the initiation site (30, 32, 35, 59). The
cis-acting elements required for maximum MLP activation have
also been identified and extensively studied both in vitro and in vivo
(7, 33, 34, 49, 50). In addition, the studies of Thomas and
Mathews (56) have demonstrated that the initiation, but not
the maintenance, of DNA replication is mandatory for the activation of
the MLP during a viral infection.
Although it was soon recognized that the late phase of infection is
accompanied by a general down-regulation of early gene expression,
initial studies of the mechanism(s) underlying control of early gene
expression were conducted under conditions in which entry into the late
phase was inhibited. The primary tools employed were inhibitors of DNA
replication (5, 11, 12, 31, 40), inhibitors of protein
synthesis (5, 11, 12, 27, 31, 40), and a
temperature-sensitive mutant in the single-stranded DNA binding protein
(DBP) (1, 5, 8), which is essential for viral DNA
replication (16). The results of these various studies
indicated that lowered expression of some early genes occurs prior to
the onset of the late phase of infection and therefore is not
contingent upon entry into the late phase. Furthermore, they suggested
that a balance of protein factors was involved in both the repression
and activation of early genes, implying a complex network of regulatory
interactions during the early phase of infection. Studies with
H5ts125, a virus with a temperature-sensitive lesion in DBP,
suggested a role of DBP in the destabilization of early mRNAs
(1) and indicated that a block in DNA replication, especially when coupled with a block in protein synthesis, allowed for
an enhanced accumulation of early viral RNAs (5). Taking all
of these previous results together, we can conclude that some form of
down-regulation of early gene expression does indeed take place during
adenovirus infection, but significant questions concerning the
mechanism remain, particularly concerning any late-phase-specific repression of early gene expression.
Previous work from our laboratory has examined the structure and
function of the MLP in the context of the complete viral genome by the
creation of mutations in known or suspected transcription elements
(34, 49, 50). Several of these mutant viruses were deficient
in viral growth and had a commensurate decrease in late RNA and protein
due to the expected decrease in MLP activity. It was also apparent that
there were other contingent effects on at least one early gene, namely
E1B, and alterations to protein accumulation over and above those
expected from the lowered expression of late gene products. In this
study, we have used these mutants to demonstrate that the expression
patterns of all early genes and of one late gene, pIX, are
significantly altered. Cells infected with MLP mutant viruses
overexpress the early genes E1A, E1B, and E2 and the late gene pIX,
they have quantitative and qualitative changes in expression of the E4
gene, and the late-phase-specific increase in expression of E3 is not
observed. These results establish that there are mechanisms of early
gene control that are dependent upon entry into the late phase and that
the previously documented down-regulation observed at late times is not
a mere temporal coincidence. Furthermore, mixed-infection experiments
provide evidence for a trans-acting mechanism of repression
of E1A, E1B, E2, and pIX. In the Discussion we consider possible models
and mutagenic strategies to explain the trans-acting
nature of early gene regulation.
 |
MATERIALS AND METHODS |
Cell culture and viral infection methods.
All analyses were
conducted with monolayer cultures of A549 human lung carcinoma cells
(19). The cells were grown in Dulbecco modified Eagle medium
with 10% supplemental calf serum (HyClone, Logan, Utah) and
antibiotics, as described previously (60). Cells to be
infected were plated in culture dishes of various sizes 1 or 2 days
prior to the addition of virus and were used when the monolayers were
confluent. Cells were infected at the multiplicities of infection (MOI)
indicated for the individual experiments.
Labeling of infected cell proteins.
A549 cell monolayers in
35-mm-diameter dishes were infected with different virus strains at the
indicated MOI. After various incubation periods, the original medium
was removed and replaced with methionine-free medium (Gibco 11970-027)
and then incubated further for 1 h. Following depletion of the
intracellular methionine pools, the medium was replaced with fresh
methionine-free medium containing 10 to 100 µCi of a mixture of
[35S]methionine and [35S]cysteine (Dupont
NEN Express NEG-072). After a 1-h incubation, cells were washed once
with 2.5 ml of phosphate-buffered saline (PBS) and then resuspended in
1 ml of PBS. Samples were analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
autoradiography as described below.
SDS-PAGE.
SDS-acrylamide gels for protein electrophoresis
were formed by using premade Protogel solutions (National Diagnostics,
Atlanta, Ga.). The separating gel contained a 12% solution of
acrylamide-bis-acrylamide at a ratio of 37.5:1. Protein samples were
mixed with an equal amount of 2× loading buffer (1.51% Tris, 20%
glycerol, 4% SDS, 10% 2-mercaptoethanol, and 0.002% bromphenol blue
[BPB]) and boiled for 2 min before loading. Samples were
electrophoresed for approximately 3 h, until the BPB dye front
reached the bottom of the separating gel. Gels were then stained for 30 min with Coomassie brilliant blue (0.25% in fixing solution of 40%
methanol and 7% glacial acetic acid) and destained for at least 2 h in fixing solution. Gels used for the resolution of radiolabelled
proteins were dried by a gel drier prior to exposure to autoradiography
film (Fuji-RX).
Western blotting.
A549 cells in 35-mm-diameter dishes were
infected with TATA0 or wild-type MLP (MLP-WT) virus. At the indicated
times p.i., infected cells were washed once in cold PBS and then
harvested by scraping into 1 ml of cold PBS. Cell resuspensions (0.1 ml) were electrophoresed and stained as described (see "SDS-PAGE" above) and then equilibrated in transfer buffer (39 mM glycine, 48 mM
Tris, 0.037% SDS, 20% methanol) for 60 min. Proteins were transferred
for 2 h to a nitrocellulose filter by using a transfer apparatus
set at 30 mA. The filter was then blocked in blocking solution (5%
nonfat dry milk in PBS) for 90 min before primary antibody exposure.
The primary antibody was an anti-E2A monoclonal antibody (courtesy of
D. F. Klessig), which was diluted 1:1,000 in blocking solution.
Filters were incubated for 90 min at room temperature in 20 ml of
diluted antibody. The filter was washed once in TBST (10 mM Tris-HCl
[pH 8.0], 150 mM NaCl, 0.05% Tween 20) and three times in PBS.
Horseradish peroxidase-conjugated goat-generated anti-mouse
immunoglobulin A (IgA), IgG, and IgM (Sigma A 0412) antiserum was used
as secondary antibody. Filters were incubated for 30 to 60 min in 15 ml
of a 1:600 dilution of this antibody in blocking solution. The filters
were then washed once in TBST and three times in PBS. Blots were
developed by chemiluminescence with the Dupont Renaissance kit (Dupont
NEL-100) and exposed to autoradiography film.
Northern blot analysis.
Total cell RNA was isolated by the
RNA STAT-60 protocol (Tel-Test "B," Inc.). Methods for Northern
blot analysis were based on a published protocol. Total infected cell
RNA (5 µg) was denatured at 55°C for 15 min in denaturation
solution (50% formamide, 18% 12.3 M [37%, wt/wt] formaldehyde, 40 mM MOPS [morpholinepropanesulfonic acid] [pH 7.0], 10 mM sodium
acetate, 1 mM EDTA). RNA loading buffer (10 µl of a solution
containing 1 mM EDTA [pH 8.0], 0.25% BPB, 0.25% xylene cyanol, and
50% glycerol) and 1 µl of ethidium bromide (10 mg/ml) were added to
each sample prior to electrophoresis. Samples were loaded onto a
formaldehyde-agarose gel (1% agarose, 18% 12.3 M [37%, wt/wt]
formaldehyde, 40 mM MOPS [pH 7.0], 10 mM sodium acetate, 1 mM EDTA)
and electrophoresed for approximately 3 h (30 mA, 80V) in a buffer
containing 40 mM MOPS (pH 7.0), 10 mM sodium acetate, and 1 mM EDTA.
Gels were washed for 15 min in deionized H2O and
equilibrated for 45 min in 10× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate). RNA was transferred via capillary action overnight
to a Genescreen Plus (Dupont NEN) filter in 10× SSC. Filters were then
either baked for 2 h under vacuum at 80°C or UV cross-linked to
immobilize transferred nucleic acids. Filters were blocked in
hybridization solution (50% formamide, 4× Denhardt's solution, 2%
SDS, 0.1 mg of salmon sperm DNA per ml, 750 mM NaCl, 150 mM Tris [pH
7.0], 18 mM NaH2PO4, 28 mM
Na2HPO4) overnight at 42°C. Samples were then
hybridized overnight at 42°C to a probe prepared by random priming of
the indicated gel-purified restriction fragment. Filters were then
washed twice at 25°C in 2× SSC, once at 42°C in 0.1× SSC-0.5%
SDS, and once at 42°C in 0.1× SSC. Filters were exposed and analyzed
by autoradiography and quantitated by either a densitometer or a
PhosphorImager.
Nuclear run-on analysis.
Nuclear run-on assays were
performed essentially as described previously (34). Between
2 × 107 and 6 × 107 cells were
infected with TATA0 or MLP-WT virus at an MOI of 10. At 22 h p.i.,
cells were washed twice with ice-cold PBS and scraped into 4 ml of PBS.
Cells were pelleted at 1,500 rpm, and PBS was removed. Cells were
vortexed briefly and resuspended during vortexing in 4 ml of Nonidet
P-40 (NP-40) lysis buffer (10 mM Tris-HCl [pH 7.4], 10 mM NaCl, 3 mM
MgCl2, 0.5% NP-40). Resuspended cells were incubated for 5 min on ice to allow lysis for isolation of intact nuclei. Nuclei were
then pelleted at 1,500 rpm. The cytoplasmic supernatant was removed,
and nuclei were resuspended in NP-40 lysis buffer and pelleted again.
Nuclear pellets were then resuspended in 200 µl of glycerol storage
buffer (50 mM Tris-HCl [pH 8.3], 40% glycerol, 5 mM
MgCl2, 0.1 mM EDTA) before the transcription reaction. An
equal volume of transcription buffer (10 mM Tris-HCl [pH 8], 5 mM
MgCl2, 0.3 M KCl, 1 mM ATP, 1 mM CTP, 1 mM GTP, 10 mM
dithiothreitol, 100 µCi of [
-32P]UTP) was added to
resuspended nuclei for a 30-min incubation at 30°C. RNase-free DNase
(RQ1; Promega) was then added to the transcription reaction mix in 0.6 ml of HSB buffer (0.5 mM NaCl, 50 mM MgCl2, 2 mM
CaCl2, 0.1 mM EDTA), which was then incubated for 5 min at
30°C. Proteinase K (200 µg at a concentration of 5µg/µl) was
then added, and the mixture was incubated for 20 min at 42°C. The
reaction product was phenol extracted and precipitated twice with
isopropanol. The pellet was washed in 75% ethanol and resuspended in
100 µl of diethyl pyrocarbonate (DEPC)-treated water. Samples were
counted with a scintillation counter, and the amounts used for
hybridization are indicated in the figure legends. Samples were added
to prehybridized filters (see below), and hybridization was for 24 to
48 h at 42°C.
Preparation of filters for nuclear run-on analysis.
Filters
were prepared with 10 to 20 µg of either single-stranded M13 or
double-stranded pBluescript DNA containing the appropriate cloned
sequence. The DNAs, in a volume of 50 µl, were added to 50 µl of
20× SSC and transferred to a Genescreen Plus filter prewetted in 10×
SSC by using a slot blot manifold. Filters were UV cross-linked and
prehybridized (see "Northern blot analysis" above).
Probes for nuclear run-on analysis.
The probes used for the
nuclear run-on assays were as follows: E1A, bp 1 to 1342 cloned into
M13mp19 or pBluescript SK(+); anti-E1A, bp 1342 to 1 cloned into
M13mp18; E1B, bp 2051 to 3331 cloned into pBluescript SK(+); E1B + pIX, bp 3328 to 3788 cloned into pSP6; MLP or E2B, bp 11555 to 13636 cloned into M13mp18 in either orientation; GAPDH (single strand),
1.3-kb PstI fragment of rat GAPDH cDNA cloned from
pBS-KS(
) (17) into M13mp19; GAPDH (double strand), 1.4-kb
EcoRI fragment of human GAPDH cDNA cloned into pGEM,
courtesy of Kartik Krishnan (13).
 |
RESULTS |
MLP-deficient viruses overexpress the E2A protein late in
infection.
Previous studies have shown that viruses containing
certain mutations in the promoter elements of the MLP exhibit a marked replication deficiency (34, 49, 50). In some mutants, this deficiency has been attributed to lowered RNA expression from the MLP,
but direct measurements of late protein accumulation were not reported.
To examine the protein profile, cells were infected with a set of
mutant viruses containing different mutations in the MLP, all of which
had significant transcriptional deficiencies. Cells were pulse labelled
with [35S]methionine at 24 h p.i. and analyzed by
SDS-PAGE. As shown in Fig. 2, all cells
infected with viruses with MLP deficiencies demonstrate, as expected, a
significant decrease in the synthesis of the major late proteins hexon,
100K, fiber, and penton base. In addition, a prominent band migrating
at about 70 kDa is considerably elevated in all of the mutant-infected
cell extracts. Thus, the protein phenotype of the deficient mutants is
consistent regardless of the specific combination of MLP mutations. All
mutant-infected cells synthesize both lowered levels of late proteins
and elevated levels of the 70-kDa species.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
Late protein synthesis in cells infected with a set of
MLP mutant viruses and the MLP-WT virus. At 24 h p.i., cell
proteins were labeled for 1 h and cell extracts were harvested,
separated by SDS-PAGE, and prepared for autoradiography, as described
in Materials in Methods. UIC, uninfected cell control.
|
|
To examine the protein phenotype further, one of the mutants was chosen
as a representative of the deficient set. Mutant TATA0
contains two
mutations within the TATA box, is significantly deficient
in
replication, and reverts much less frequently to a wild-type
phenotype
than does TATA27::CCCAT (
37a). As before, proteins
in TATA0- and wild type-infected cells were analyzed by SDS-PAGE
at 18 and 24 h p.i. (Fig.
3A).
Quantitation of individual protein
bands (Fig.
3B) revealed that the
synthesis of hexon was reduced
about fivefold at 18 and 24 h p.i.
in the mutant-infected cells,
compared with the wild type-infected
cells. Synthesis of fiber
was reduced by at least fourfold at 18 h
p.i. and to nearly background
levels at 24 h p.i., while
measurements of penton base were indistinguishable
from the background
level. The 70-kDa protein was increased by
2.5-fold (18 h) and 8-fold
(24 h) in TATA0-infected cells. (Fig.
2B; Table
1). Quantitation of other infections
showed similar
reductions in late proteins and increases in the 70-kDa
protein
(data not shown).

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 3.
Late protein synthesis in TATA0- and MLP-WT-infected
cells. At 18 or 24 h p.i., cells were labeled and cell extracts
were harvested as described in Materials and Methods. (A) Autoradiogram
of labeled proteins separated by SDS-PAGE. (B) Quantitation of relative
band intensities, as determined with a PhosphorImager.
|
|
The identity of the 70-kDa protein was unknown, but several possible
viral and cellular candidates were considered. Because
it was expressed
in both wild type- and mutant-infected cells,
a viral protein was
suspected, and its relative mobility suggested
that it might be the
single-stranded DNA binding protein DBP.
Western blot analysis was
performed to test this (Fig.
4A). At
12, 18, and 24 h p.i., levels of DBP in TATA0-infected cells were
elevated between 5 and 15-fold compared with the wild type (Fig.
4B;
Table
1). This corresponds to the increase in synthesis of
the protein
of similar relative mobility shown in Fig.
3A. Western
blot analysis
established that there is a significant increase
in DBP expression at
late times in mutant-infected cells and suggests
that lowered MLP
expression is accompanied by increased early
gene 2 expression. Coupled
with the previous observation that
E1B RNA levels are elevated in MLP
mutant-infected cells (
50),
this result suggests that
expression of the MLP and of at least
some early genes are inversely
correlated.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
E2A accumulation in TATA0- and MLP-WT-infected cells. At
the indicated times p.i. (in hours), cell extracts were harvested and
cell proteins were resolved via SDS-PAGE. (A) Western transfer and
antibody detection of E2A. (B) Relative levels of E2A, as determined by
densitometry.
|
|
Analysis of RNA levels in MLP mutant- and wild type-infected
cells.
The results described above and previously suggest that
decreases in MLP expression lead to corresponding increases in the expression of at least two early genes. It was of some interest to see
if these effects could be extended to other early and late genes and to
begin the analysis of the level at which these effects occur.
Accordingly, a survey of quantitative changes to steady-state viral
mRNAs was conducted by using Northern blot analysis. Probes capable of
hybridizing to E1A, E1B, E2A, E3, and E4, as well as late gene pIX,
were used in the analysis (Fig. 5; Table
1). At the indicated times both early and late in infection, total RNA was isolated from cells infected with MLP-WT or TATA0. Levels of RNA
from several genes were overexpressed in TATA0-infected cells. E1A mRNA
levels were equivalent at 10 h p.i. but at 24 h p.i. were
overexpressed threefold by TATA0 (Fig. 5A and F; Table 1). At 12 h
p.i., E1B and pIX mRNA was detected in cells infected with TATA0 but
not with MLP-WT; at 24 h p.i., E1B 55K levels were 10 times higher
and pIX levels were 4 times higher in TATA0-infected cells (Fig. 5B and
G; Table 1). L4 mRNA accumulated to levels three times higher in
MLP-WT-infected cells by 24 h p.i., and E2A levels were four times
higher in TATA0-infected cells at 12 h p.i.; at 24 h p.i.,
E2A mRNA was detected in TATA0- but not in MLP-WT-infected cells (Fig.
5C and H; Table 1). A different effect was observed with E3 expression:
at 12 h p.i., there was little difference in E3 region mRNA; at
24 h p.i., however, there was a greater increase in message levels
in the MLP-WT-infected cells than in those infected with TATA0 (Fig. 5D
and I; Table 1). Although the exact identification of the three
prominent species of RNA is difficult since the E3 region of this virus is highly recombinant (7), we infer that the two lower bands (labeled A and B in Fig. 5D) are E3 species rather than MLP-specific RNAs, because on a longer exposure these bands are visible at 6 h
p.i., before full MLP activation (data not shown). Nevertheless, the
relative increase in expression of E3, compared with E1A, E1B, E2A, and
pIX RNAs in wild-type as opposed to mutant infection, may reflect the
fact that some E3 species are expressed from the MLP late in infection,
a phenomenon previously demonstrated for the E3 11.6K gene
(58). Thus, the increase in the wild-type infection may
reflect the greater transcriptional abilities of the wild-type MLP.
Northern analysis of the E4 region (Fig. 5E) showed yet a different
change in gene expression due to reduced MLP activity: the use of a
probe complementary to the 3' end of all E4 messages revealed both
qualitative and quantitative changes in the accumulation of E4 RNA
species. This complex pattern of changes was not explored further.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 5.
Early and late message accumulation in TATA0- and
MLP-WT-infected cells. At the indicated times p.i., total RNA was
harvested and Northern blot analyses of early and late messages were
performed as described in Materials and Methods. The blots were probed
with the following random-primed double-stranded DNA sequences: bp 342 to 1342 (E1A) (A), bp 3328 to 3788 (E1B, pIX) (B), bp 23039 to 23912 (E2A, L4 100K, L4 URF) (C), bp 28879 to 29602 (E3) (D), and bp 31920 to
32423 (E4) (E). The corresponding relative levels of mRNA species (F to
I) were determined by densitometry and corrected for total RNA levels
by reprobing of stripped blots with either actin or GAPDH. The precise
sequence identities of bands labeled A and B in panel D are unknown.
The bands in panel E were not identified as to specific open reading
frames and are thus left unlabeled.
|
|
With the results from the Northern analyses taken together, it is clear
that changes to expression from the MLP are accompanied
by profound
changes in expression from many if not all of the
other genes encoded
in the adenovirus genome. One possibility
arising from these results is
that the MLP and/or the products
of the MLTU play roles in the
regulation of most other adenovirus
genes at late times in infection.
Methods to determine whether
this role is active or merely contingent
will be discussed later.
Comparison of relative early and late promoter strengths in TATA0-
and MLP-WT-infected cells.
The results described above show that
there are significant changes in the relative abundance of viral RNA
species in cells infected with a virus having a severely deficient MLP.
To determine the level of gene expression at which these changes are
exerted, it is necessary to examine the first step, namely
transcription initiation. This was examined by nuclear run-on
experiments using nuclei harvested at 22 h p.i. Radiolabelled de
novo transcripts were hybridized to DNA probes on membranes, and levels
of hybridization were quantified. MLP promoter activity was reduced in
TATA0-infected cells (Fig. 6A and B;
Table 1) to some 60% of the wild-type level in the two experiments
shown. In contrast, the relative rates of E1B, pIX, and E2B
transcription were elevated about threefold (Fig. 6; Table 1). The
relative rate of E1A transcription was also elevated some threefold in
TATA0-infected cells in two of the three experiments represented by
Fig. 6; the small decrease observed in one experiment (Fig. 6A and D)
was not seen in two other experiments and is probably a loading
artifact.

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of relative promoter strengths in TATA0- and
MLP-WT-infected cells. At 22 h p.i., nuclei were harvested and
transcription reactions were performed in vitro in the presence of 100 µCi of [ -32P]UTP. De novo transcripts were isolated
and hybridized to filters containing unlabeled DNA probes, as indicated
to the left of panels A to C. Filters were washed and then exposed by
autoradiography: 107 cpm were hybridized to single-stranded
M13 DNA probes (A), 106 cpm were hybridized to
single-stranded DNA probes (B), and 106 cpm were hybridized
to double-stranded DNA probes (C). (D to F) Quantitation of the counts
hybridized to each of the probes shown in panels A to C. The values
were normalized as follows. First, background values (anti-E1A in panel
A and pUC18 in panel C) were subtracted from each of the experimental
values. Background values were not subtracted for the data in panel B
because this had the effect of making the decrease in activity of the
MLP and the increase in E1A activity from TATA0-infected nuclei
anomolously high compared with all other experiments. After subtraction
of background, the corrected values were normalized to the
hybridization to GAPDH.
|
|
Despite the difficulties inherent in interpreting small changes in
transcription initiation, we conclude from these results
that the
increased steady-state RNA levels observed in the Northern
analysis
(Fig.
5) are correlated with increased levels of initiation.
Complementation of the overexpression of early genes in MLP
mutant-infected cells by wild-type coinfection.
The results
presented above suggest that lowered expression from the MLP at late
times in infection is correlated with an increased expression of other
viral genes at the level of transcription initiation. These changes in
expression could be exerted either in cis or in
trans, and which of these two alternatives is correct has
mechanistic implications. For example, a finding that changes in
expression are mediated in cis would exclude mechanisms
involving diffusible regulatory factors. On the other hand, a finding
that the increases in early gene expression occur by a
trans-acting mechanism would exclude such models as the
occlusion of early promoters by active transcription from the MLP.
To address the issue of whether or not changes in gene expression are
mediated in
cis or in
trans, cells were
coinfected with
wild-type adenovirus type 5 (Ad5-WT) and TATA0 at
various input
multiplicities, and measurements were made of
representative viral
proteins and steady-state RNA levels. In the first
experiment,
cells were infected with a constant multiplicity of TATA0
virus
and with increasing amounts of Ad5-WT; at 24 h p.i.,
proteins
were labeled for 1 h. Infected cell proteins were
analyzed by
SDS-PAGE. As shown in Fig.
7,
the relative level of DBP synthesized
in the TATA0-infected cells was
reduced to that of the wild type
upon coinfection with wild-type virus,
and the relative level
of a representative late protein, penton base,
was increased to
wild-type levels. This experiment suggests that the
changes to
early gene expression observed in TATA0-infected cells are
mediated
in
trans. A similar experiment was performed with
TATA0 and MLP-WT,
and essentially identical results were obtained (data
not shown).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 7.
E2A protein synthesis in TATA0-infected cells coinfected
with Ad5-WT. Cells were infected with the indicated MOI of TATA0 and
Ad5-WT; at 24 h p.i., cells were labeled with 100 µCi of
[35S]methionine for 1 h and cell extracts were
prepared. (A) Autoradiogram of the labeled proteins separated by
SDS-PAGE. (B) Quantitation of relative intensities of the E2A and
penton base proteins determined by densitometry.
|
|
To extend these observations to other early genes and the pIX gene, we
measured the steady-state levels of RNA in coinfected
cells. Total cell
RNA was harvested and Northern blot analysis
was performed with probes
complementary to E1A (Fig.
8A and C)
or
E1B and pIX (Fig.
8B and D). The results at the RNA level were
similar
to those observed at the protein level. Upon coinfection
with an
equivalent multiplicity of MLP-WT, E1A mRNA levels were
reduced to
wild-type levels. In TATA0-infected cells, E1B and
pIX mRNA levels
showed a dose-dependent reduction of mRNA to near
wild-type levels upon
coinfection with MLP-WT. These results demonstrate
a global
trans effect on changes in gene expression in MLP
mutant-infected
cells and will help us in further defining the
mechanism(s) underlying
these changes.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 8.
Early and late mRNA accumulation in infected cells
coinfected with TATA0 and MLP-WT. Cells were infected with the
indicated MOI of TATA0 and MLP-WT. At 20 h p.i. (A) or 24 h
p.i. (B), total RNA was harvested from infected cells and analyzed by
Northern blot hybridization. The random-primed double-stranded DNA
probes were as follows: bp 906 to 1342 (E1A) (A); bp 3328 to 3788 (E1B,
pIX) (B). (C and D) Quantitation of relative band intensities, as
determined by PhosphorImager, corrected for loading of RNA by reprobing
of stripped blots with a GAPDH probe.
|
|
 |
DISCUSSION |
Gene expression in adenovirus infection undergoes major
quantitative and temporal changes during the viral replicative cycle. The gene regulation underlying these changes is comprised of an extensive network of gene products and cis-acting sequences,
as summarized in Table 2. The most
prominent temporal change in gene expression is the early-to-late
switch in infection punctuated by the commencement of viral DNA
replication. Although the phenomenon of the early-to-late switch, i.e.,
full activation of late genes with a corresponding decrease in early
gene expression, has been described, the mechanistic forces involved in
facilitating this change have yet to be demonstrated. It has been shown
that full activation of the MLP is not only boosted by E1A and IVa2 but that there is also a requirement for the initiation, but not the maintenance, of DNA replication for full MLP activation
(56). In addition, the activation and repression of early
gene expression was shown to be mediated by a balance of labile protein
activators and repressors (5, 11, 12, 27, 31, 40, 54).
Previous experiments in our laboratory have defined the
cis-acting elements necessary for full activation of the MLP
in the correct genomic context. As well as providing genetic evidence for the importance of specific promoter elements to the function of the
MLP, viruses with mutant MLPs also can be used to explore the
phenomenon of the reduction of early gene expression late in infection
and to begin to answer questions as to the mechanism(s) underlying this
poorly understood phenomenon. Using TATA0, an MLP mutant virus
harboring a double mutation in the TATA box, we show that expression of
the early genes E1A, E1B, and E2 and the late gene pIX is inversely
correlated with expression from the MLP, as the former genes are
overexpressed by the MLP mutant virus. The increases in expression of
these genes ranged from some 3-fold to as much as 15-fold, depending on
the specific gene and the level at which the measurement was made
(Table 1). It should be emphasized that although the magnitude of
increase varied with the level at which gene expression was measured
(transcription initiation, steady-state level of RNA, protein
synthesis, or protein accumulation), all measurements showed an
increase. While subtle differences in the precise mechanisms underlying
the increases for expression of specific genes cannot be ruled out, the
uniformity of the trend suggests a single mechanism for the increases.
There were two exceptions to the general trend of increased expression
of early genes and the late gene pIX in MLP-deficient viruses.
Measurement of steady-state E3 RNA levels showed a marked increase in
MLP-WT-infected cells compared with those infected with TATA0 (Fig. 5D
and I). Although we have not identified the species expressed from the
E3 region of this pair of viruses, the viral genomes are both derived
from Ad2+ND1, an adenovirus type 2-simian virus 40 chimera
(28). It is possible that some or all of the species are
derived from spliced transcripts expressed from the MLP at late times
in infection, as is the case for the 11.6-kDa protein, the adenovirus
"death protein" ADP (57). If this interpretation is
correct, then the increase in E3 species in the MLP-WT infection is
precisely as predicted. The other exception is the anomalous behavior
of RNAs expressed from E4 (Fig. 5E). In TATA0-infected cells, a
transient increase in E4 species at 12 h p.i. is followed by
virtual disappearance of species hybridizing to a 3' probe. Similar
results have been obtained in several other experiments (data not
shown). It has been known for some time that the E4 transcription unit
is subject to complex temporal regulation at the level of splicing
(14). How lowered expression from the MLP could lead to the
results shown in Fig. 5E is not known, although competition for
limiting splicing machinery components might contribute to the observed phenotype.
The results discussed above show that lowered expression from the MLP
at late times in infection leads to significant increases in expression
from some early and late transcription units. These increases can be
traced in part to increases in transcription initiation (Fig. 6) and
raise the question as to the mechanisms(s) underlying these changes in
gene expression. Given that four transcription units are affected, it
seems likely that the mechanism is general rather than promoter
specific. Hypotheses concerning mechanism would be clarified by
knowledge of whether the mechanism operates in cis, in which
case the increases in gene expression would not be affected by
coinfection with the wild-type virus, or in trans, in which
case the increases would be reversed by such coinfection. The results
of such coinfections are presented in Fig. 7 and strongly support the
idea that the mechanism operates in trans. Coinfection with
the wild-type virus leads to a reduction in the levels of increase of
72K DBP and E1A, E1B, and pIX RNAs in mutant-infected cells. This
result rules out simple cis-acting mechanisms, such as
template-specific effects both upstream and downstream of the MLP.
The genetic results shown in Fig. 7 suggest some
trans-mediated mechanism for the lowered levels of early
gene expression in the wild type-infected cells. Furthermore, we can
hypothesize that the lowered levels of such expression are important
for the efficient completion of the viral replicative cycle. Two types of general models may account for these effects. "Passive" models include a promoter competition mechanism, in which the MLP competes with other promoters for rate-limiting components of the
transcriptional machinery. For example, it is known that both the E2E
and E2L promoters contain nonconsensus TATA box sequences (reviewed in reference 52). If the nonconsensus TACAAA
sequence of the E2L promoter is altered to the consensus
TATAAA, there is a large increase in in vitro promoter
activity (23). Perhaps there is a biological advantage to
maintaining a nonconsensus TATA box in the E2 promoters, because they
may fail to compete with the MLP, which contains a consensus TATA box,
at late times in infection. While a simple promoter competition model
could account for the results with the E2 promoters, and perhaps the
simple E1B and pIX promoters, it is hard to envisage such a mechanism
operating at the E1A promoter, because it contains a strong enhancer
element (3). Genetic experiments to test the promoter
competition model at the E2L promoter are underway. The alternative
"active" models propose that the MLTU encodes a diffusible factor
that down-regulates other promoters. Possible candidates could include
nonstructural proteins such as the L1 52,55K protein, the L3 23K
protease, or the L4 100K or 33K protein. Extensive phenotypic
characterization of temperature-sensitive mutants of the first three
proteins has not included a detailed analysis of transcriptional
effects, and this is currently under investigation. There are no
reports of mutations in the 33K protein, a conserved phosphoprotein of
unknown function (9) which accumulates in the nucleus at
late times in infection (18). Recently, we created a virus
in which the function of the 33K gene is mutated; although this virus
has a pronounced growth defect, there are no detectable changes in
early gene expression (16a). Thus, it is not a candidate for
a putative MLTU-encoded repressor.
 |
ACKNOWLEDGMENTS |
This work was supported by grant R01 GM49070 from the NIGMS and
by a core grant from the NCI to the Columbia Comprehensive Cancer
Center (CA13696).
We thank Pat Munz for valuable technical assistance and the members of
the virology group for discussions and advice.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Columbia University, HHSC 1308, 701 W. 168th St., New
York, NY 10032. Phone: (212) 305-4179. Fax: (212) 305-1468. E-mail: csy1{at}columbia.edu.
 |
REFERENCES |
| 1.
|
Babich, A., and J. R. Nevins.
1981.
The stability of early adenovirus mRNA is controlled by the viral 72K DNA binding protein.
Cell
26:371-379[Medline].
|
| 2.
|
Babiss, L. E.,
H. S. Ginsberg, and J. E. Darnell.
1985.
Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.
Mol. Cell. Biol.
5:2552-2558[Abstract/Free Full Text].
|
| 3.
|
Berk, A. J.
1986.
Adenovirus promoters and E1A transactivation.
Annu. Rev. Genet.
20:45-79[Medline].
|
| 4.
|
Berk, A. J.,
F. Lee,
T. Harrison,
J. Williams, and P. A. Sharp.
1979.
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.
Cell
17:935-944[Medline].
|
| 5.
|
Binger, M. H., and S. J. Flint.
1984.
Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections.
Virology
136:387-403[Medline].
|
| 6.
|
Bridge, E.,
C. Hemström, and U. Pettersson.
1991.
Differential regulation of adenovirus late transcriptional units by the products of early region.
Virology
183:260-266[Medline].
|
| 7.
|
Brunet, L. J.,
L. E. Babiss,
C. S. H. Young, and D. R. Mills.
1987.
Mutations in the adenovirus major late promoter: effects upon viability and transcription during infection.
Mol. Cell. Biol.
7:1091-1100[Abstract/Free Full Text].
|
| 8.
|
Carter, T. H., and R. A. Blanton.
1978.
Possible role of the 72,000-dalton DNA binding protein in regulation of adenovirus type 5 early gene expression.
J. Virol.
25:664-674[Abstract/Free Full Text].
|
| 9.
|
Cauthen, A. N., and K. R. Spindler.
1996.
Sequence of the mouse adenovirus type-1 DNA encoding the 100-kDa, 33-kDa and DNA-binding proteins.
Gene
168:183-187[Medline].
|
| 10.
|
Chang, L.-S., and T. Shenk.
1990.
The adenovirus DNA-binding protein stimulates the rate of transcription directed by adenovirus and adeno-associated virus promoters.
J. Virol.
64:2103-2109[Abstract/Free Full Text].
|
| 11.
|
Craig, E. A., and H. J. Raskas.
1974.
Effect of cycloheximide on RNA metabolism early in productive infection with adenovirus 2.
J. Virol.
14:26-32[Abstract/Free Full Text].
|
| 12.
|
Cross, F. R., and J. E. Darnell, Jr.
1983.
Cycloheximide stimulates early adenovirus transcription if early gene expression is allowed before treatment.
J. Virol.
45:683-692[Abstract/Free Full Text].
|
| 13.
|
Davis, E.,
K. Krishnan,
H. Yan,
E. Newcomb, and J. J. Krolewski.
1996.
A mutant form of p135tyk2, an interferon inducible tyrosine kinase, can suppress tumorigenicity.
Leukemia
10:543-551[Medline].
|
| 14.
|
Dix, I., and K. N. Leppard.
1993.
Regulated splicing of adenovirus type 5 E4 transcripts and regulated cytoplasmic accumulation of E4 mRNA.
J. Virol.
67:3226-3231[Abstract/Free Full Text].
|
| 15.
|
Dolph, P. J.,
J. Huang, and R. J. Schneider.
1991.
Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding complex.
J. Virol.
64:2669-2677.
|
| 16.
|
Ensinger, M. J., and H. S. Ginsberg.
1972.
Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus.
J. Virol.
10:328-339[Abstract/Free Full Text].
|
| 16a.
| Fessler, S. P., and C. S. H. Young.
Unpublished results.
|
| 17.
|
Fort, P.,
L. Marty,
M. Piechaczyk,
S. El Sabrouty,
C. Dani,
P. Jennteur, and J. M. Blanchard.
1985.
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigene family.
Nucleic Acids Res.
13:1431-1442[Abstract/Free Full Text].
|
| 18.
|
Gambke, C., and W. Deppert.
1981.
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. I. Subcellular localization during the course of infection.
J. Virol.
40:585-593[Abstract/Free Full Text].
|
| 19.
|
Giard, D. J.,
S. A. Aaronson,
G. J. Todaro,
P. Arnstein,
J. H. Kersey,
H. Dosik, and W. P. Parks.
1973.
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.
J. Natl. Cancer Inst.
51:1417-1423.
|
| 20.
|
Gilmartin, G. M.,
S. L. Hung,
J. D. DeZazzo,
E. S. Fleming, and M. J. Imperiale.
1996.
Sequences regulating poly(A) site selection within the adenovirus major late transcription unit influence the interaction of constitutive processing factors with the pre-mRNA.
J. Virol.
70:1775-1783[Abstract].
|
| 21.
|
Hardy, S.,
D. A. Engel, and T. Shenk.
1989.
An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity.
Genes Dev.
3:1062-1074[Abstract/Free Full Text].
|
| 22.
|
Hayes, B. W.,
G. C. Telling,
M. M. Myat,
J. F. Williams, and S. J. Flint.
1990.
The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species.
J. Virol.
64:2732-2742[Abstract/Free Full Text].
|
| 23.
|
Huang, D.-H.,
M. Horikoshi, and R. G. Roeder.
1988.
Activation of the adenovirus EIIa late promoter by a single-point mutation which enhances binding of transcription factor IID.
J. Biol. Chem.
263:12596-12601[Abstract/Free Full Text].
|
| 24.
|
Huang, M.-M., and P. Hearing.
1989.
The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex.
Genes Dev.
3:1699-1710[Abstract/Free Full Text].
|
| 25.
|
Huang, M.-M., and P. Hearing.
1989.
Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection.
J. Virol.
63:2605-2615[Abstract/Free Full Text].
|
| 26.
|
Jones, N., and T. Shenk.
1979.
An adenovirus type 5 early gene function regulates expression of other early viral genes.
Proc. Natl. Acad. Sci. USA
76:3665-3669[Abstract/Free Full Text].
|
| 27.
|
Katze, M. G.,
H. Persson, and L. Philipson.
1981.
Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products.
Mol. Cell. Biol.
1:807-813[Abstract/Free Full Text].
|
| 28.
|
Kelly, T. J., Jr., and A. M. Lewis, Jr.
1973.
Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.
J. Virol.
12:643-652[Abstract/Free Full Text].
|
| 29.
|
Kreivi, J.-P.,
K. Zerivitz, and G. Akusjärvi.
1991.
Sequences involved in the control of adenovirus L1 alternative RNA splicing.
Nucleic Acids Res.
19:2379-2386[Abstract/Free Full Text].
|
| 30.
|
Leong, K.,
W. Lee, and A. J. Berk.
1990.
High-level transcription from the adenovirus major late promoter requires downstream binding sites for late-phase-specific factors.
J. Virol.
64:51-60[Abstract/Free Full Text].
|
| 31.
|
Lewis, J. B., and M. B. Mathews.
1980.
Control of adenovirus early gene expression: a class of immediate early products.
Cell
21:303-313[Medline].
|
| 32.
|
Li, X.-C.,
W. L. Huang, and S. J. Flint.
1992.
The downstream regulatory sequence of the adenovirus type 2 major late promoter is functionally redundant.
J. Virol.
66:5685-5690[Abstract/Free Full Text].
|
| 33.
|
Logan, J., and T. Shenk.
1986.
In vivo identification of sequence elements required for normal function of the adenovirus major late transcriptional control region.
Nucleic Acids Res.
14:6327-6335.
|
| 34.
|
Lu, H.,
M. D. Reach,
E. Minaya, and C. S. H. Young.
1997.
The initiator element of the adenovirus major late promoter has an important role in transcription initiation in vivo.
J. Virol.
71:102-109[Abstract].
|
| 35.
|
Lutz, P., and C. Kedinger.
1996.
Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter.
J. Virol.
70:1396-1405[Abstract].
|
| 36.
|
Lutz, P.,
M. Rosa-Calatrava, and C. Kedinger.
1997.
The product of the adenovirus intermediate gene IX is a transcriptional activator.
J. Virol.
71:5102-5109[Abstract].
|
| 37.
|
Mathews, M. B.
1990.
Control of translation in adenovirus-infected cells.
Enzyme
44:250-264[Medline].
|
| 37a.
| Minaya, E., S. P. Fessler, and C. S. H. Young. Unpublished results.
|
| 38.
|
Nevins, J. R.
1981.
Mechanism of activation of early viral transcription by the adenovirus E1a gene product.
Cell
26:213-220[Medline].
|
| 39.
|
Nevins, J. R.
1987.
Regulation of early adenovirus gene expression.
Microbiol. Rev.
51:419-430[Free Full Text].
|
| 40.
|
Nevins, J. R.,
H. S. Ginsberg,
J.-M. Blanchard,
M. C. Wilson, and J. E. Darnell.
1979.
Regulation of the primary expression of the early adenovirus transcription units.
J. Virol.
32:727-733[Abstract/Free Full Text].
|
| 41.
|
Nevins, J. R., and M. C. Wilson.
1981.
Regulation of adenovirus-2 gene expression at the level of transcription termination and RNA processing.
Nature
290:113-118[Medline].
|
| 42.
|
Nordqvist, K., and G. Akusjärvi.
1990.
Adenovirus early region 4 stimulates mRNA accumulation via 5' introns.
Proc. Natl. Acad. Sci. USA
87:9543-9547[Abstract/Free Full Text].
|
| 43.
|
Nordqvist, K.,
K. Öhman, and G. Akusjärvi.
1994.
Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs.
Mol. Cell. Biol.
14:437-445[Abstract/Free Full Text].
|
| 44.
|
O'Connor, R. J., and P. Hearing.
1991.
The C-terminal 70 amino acids of the adenovirus E4-ORF6/7 protein are essential and sufficient for E2F complex formation.
Nucleic Acids Res.
19:6579-6586[Abstract/Free Full Text].
|
| 45.
|
Pilder, S.,
M. Moore,
J. Logan, and T. Shenk.
1986.
The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs.
Mol. Cell. Biol.
6:470-476[Abstract/Free Full Text].
|
| 46.
|
Prescott, J., and E. Falck-Pedersen.
1994.
Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.
Mol. Cell. Biol.
14:4682-4693[Abstract/Free Full Text].
|
| 47.
|
Prescott, J. C., and E. Falck-Pedersen.
1992.
Varied poly(A) site efficiency in the adenovirus major late transcription unit.
J. Biol. Chem.
267:8175-8181[Abstract/Free Full Text].
|
| 48.
|
Prescott, J. C.,
L. Liu, and E. Falck-Pedersen.
1997.
Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.
Mol. Cell. Biol.
17:2207-2216[Abstract].
|
| 49.
|
Reach, M.,
L. E. Babiss, and C. S. H. Young.
1990.
The upstream factor binding site is not essential for activation of transcription from the adenovirus major late promoter.
J. Virol.
64:5851-5860[Abstract/Free Full Text].
|
| 50.
|
Reach, M.,
L.-X. Xu, and C. S. H. Young.
1991.
Transcription from the adenovirus major late promoter uses redundant activating elements.
EMBO J.
10:3439-3446[Medline].
|
| 51.
|
Sandler, A. B., and G. Ketner.
1991.
The metabolism of host RNAs in cells infected by an adenovirus E4 mutant.
Virology
181:319-326[Medline].
|
| 52.
|
Sharp, P. A.
1984.
Adenovirus transcription, p. 173-204.
In
H. S. Ginsberg (ed.), The adenoviruses. Plenum Press, New York, N.Y.
|
| 53.
|
Shaw, A. R., and E. B. Ziff.
1980.
Transcripts from the adenovirus-2 major late promoter yield a single early family of 3' coterminal mRNAs and five late families.
Cell
20:905-916.
|
| 54.
|
Shaw, A. R., and E. B. Ziff.
1982.
Selective inhibition of adenovirus type 2 early region II and III transcription by an anisomycin block of protein synthesis.
Mol. Cell. Biol.
2:789-799[Abstract/Free Full Text].
|
| 55.
|
Shenk, T., and S. J. Flint.
1991.
Transcriptional and transforming activities of the adenovirus E1A proteins.
Adv. Cancer Res.
57:47-85[Medline].
|
| 56.
|
Thomas, G. P., and M. B. Mathews.
1980.
DNA replication and the early to late transition in adenovirus infection.
Cell
22:523-533[Medline].
|
| 57.
|
Tollefson, A. E.,
A. Scaria,
T. Hermiston,
J. S. Ryerse,
L. J. Wold, and W. S. M. Wold.
1996.
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.
J. Virol.
70:2296-2306[Abstract].
|
| 58.
|
Tollefson, A. E.,
A. Scaria,
S. K. Saha, and W. S. M. Wold.
1992.
The 11,600-Mw protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection.
J. Virol.
66:3633-3642[Abstract/Free Full Text].
|
| 59.
|
Tribouley, C.,
P. Lutz,
A. Staub, and C. Kedinger.
1994.
The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter.
J. Virol.
68:4450-4457[Abstract/Free Full Text].
|
| 60.
|
Volkert, F. C., and C. S. H. Young.
1983.
The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments.
Virology
125:175-193[Medline].
|
J Virol, May 1998, p. 4049-4056, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Timpe, J. M., Verrill, K. C., Trempe, J. P.
(2006). Effects of Adeno-Associated Virus on Adenovirus Replication and Gene Expression during Coinfection.. J. Virol.
80: 7807-7815
[Abstract]
[Full Text]
-
Faiger, H., Ivanchenko, M., Cohen, I., Haran, T. E.
(2006). TBP flanking sequences: asymmetry of binding, long-range effects and consensus sequences. Nucleic Acids Res
34: 104-119
[Abstract]
[Full Text]
-
Shepard, R. N., Ornelles, D. A.
(2004). Diverse Roles for E4orf3 at Late Times of Infection Revealed in an E1B 55-Kilodalton Protein Mutant Background. J. Virol.
78: 9924-9935
[Abstract]
[Full Text]
-
Holm, P. S., Lage, H., Bergmann, S., Jurchott, K., Glockzin, G., Bernshausen, A., Mantwill, K., Ladhoff, A., Wichert, A., Mymryk, J. S., Ritter, T., Dietel, M., Gansbacher, B., Royer, H.-D.
(2004). Multidrug-resistant Cancer Cells Facilitate E1-independent Adenoviral Replication: Impact for Cancer Gene Therapy. Cancer Res.
64: 322-328
[Abstract]
[Full Text]
-
Lohr, K., Hartmann, O., Schafer, H., Dobbelstein, M.
(2003). Mutual Interference of Adenovirus Infection and myc Expression. J. Virol.
77: 7936-7944
[Abstract]
[Full Text]
-
Holm, P. S., Bergmann, S., Jurchott, K., Lage, H., Brand, K., Ladhoff, A., Mantwill, K., Curiel, D. T., Dobbelstein, M., Dietel, M., Gansbacher, B., Royer, H.-D.
(2002). YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter. J. Biol. Chem.
277: 10427-10434
[Abstract]
[Full Text]
-
Russell, W. C.
(2000). Update on adenovirus and its vectors. J. Gen. Virol.
81: 2573-2604
[Full Text]
-
Wolner, B. S., Gralla, J. D.
(2000). Roles for Non-TATA Core Promoter Sequences in Transcription and Factor Binding. Mol. Cell. Biol.
20: 3608-3615
[Abstract]
[Full Text]